UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

Breast (Edinburgh), 2024-10, Vol.77, p.103765, Article 103765

2024

Volltextzugriff (PDF)

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Breast (Edinburgh), 2015-06, Vol.24 (3), p.201-207

2015

Volltextzugriff (PDF)

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Breast (Edinburgh), 2010-10, Vol.19 (5), p.388-395

2010

Volltextzugriff (PDF)

Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient

Breast (Edinburgh), 2013-08, Vol.22 Suppl 2, p.S3-S7

Goldhirsch, Aron

2013

Volltextzugriff (PDF)

Personalized adjuvant therapies: Lessons from the past

Breast (Edinburgh), 2013-08, Vol.22, p.S3-S7

Goldhirsch, Aron

2013

Volltextzugriff (PDF)

Autologous fat transplantation in patients with breast cancer: “silencing” or “fueling” cancer recurrence?

Breast (Edinburgh), 2011-08, Vol.20 (4), p.351-357

2011

Volltextzugriff (PDF)

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer

Breast (Edinburgh), 2014-02, Vol.23 (1), p.69-75

2014

Volltextzugriff (PDF)

Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting

Breast (Edinburgh), 2009-10, Vol.18, p.S137-S140

2009

Volltextzugriff (PDF)

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Breast (Edinburgh), 2013-12, Vol.22 (6), p.1094-1100

2013

Volltextzugriff (PDF)

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

Breast (Edinburgh), 2013-10, Vol.22 (5), p.650-656

2013

Volltextzugriff (PDF)

Pathological features and survival outcomes of very young patients with early breast cancer: How much is “very young”?

Breast (Edinburgh), 2013-12, Vol.22 (6), p.1046-1051

2013

Volltextzugriff (PDF)

Biopsy of liver metastasis for women with breast cancer: Impact on survival

Breast (Edinburgh), 2012-06, Vol.21 (3), p.284-288

2012

Volltextzugriff (PDF)

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine

Breast (Edinburgh), 2015-06, Vol.24 (3), p.263-271

2015

Volltextzugriff (PDF)

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care

Breast (Edinburgh), 2017-02, Vol.31, p.241-243

2017

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

Breast (Edinburgh), 2011-08, Vol.20 (4), p.319-323

2011

Volltextzugriff (PDF)

Developing an effective breast cancer vaccine: Challenges to achieving sterile immunity versus resetting equilibrium

Breast (Edinburgh), 2013-08, Vol.22, p.S96-S99

2013

Volltextzugriff (PDF)

Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research

Breast (Edinburgh), 2006-02, Vol.15 (1), p.3-8

2006

Volltextzugriff (PDF)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial

Breast (Edinburgh), 2013-04, Vol.22 (2), p.130-137

2013

Volltextzugriff (PDF)

Immunizing against breast cancer: A new swing for an old sword

Breast (Edinburgh), 2009-10, Vol.18, p.S51-S54

2009

Volltextzugriff (PDF)

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab

Breast (Edinburgh), 2012-06, Vol.21 (3), p.309-313

2012

Volltextzugriff (PDF)

Results of chest wall resection for recurrent or locally advanced breast malignancies

Breast (Edinburgh), 2007-06, Vol.16 (3), p.297-302

2007

Volltextzugriff (PDF)

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

Breast (Edinburgh), 2008, Vol.17 (5), p.506-511

2008

Volltextzugriff (PDF)

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

Breast (Edinburgh), 2011-02, Vol.20 (1), p.34-38

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBreast

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Obstetrics & Gynecology
(30)
Oncology
(30)
Science & Technology
(30)
Female
(28)
Humans
(28)
Hematology, Oncology And Palliative Medicine
(25)
Breast Cancer
(21)
Breast Neoplasms - Drug Therapy
(18)
Adult
(15)
Middle Aged
(15)
Breast Neoplasms - Pathology
(14)
Aged
(13)
Chemotherapy, Adjuvant
(9)
Treatment Outcome
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Breast Neoplasms - Surgery
(8)
Prognosis
(8)
Antineoplastic Agents, Hormonal - Therapeutic Use
(7)
Disease-Free Survival
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(34)
EZB Electronic Journals Library
(34)
Ingenta
(34)
Elsevier ScienceDirect Journals
(34)
MEDLINE
(29)
IngentaConnect Journals
(25)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Breast
(2)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient

Personalized adjuvant therapies: Lessons from the past

Autologous fat transplantation in patients with breast cancer: “silencing” or “fueling” cancer recurrence?

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

Pathological features and survival outcomes of very young patients with early breast cancer: How much is “very young”?

Biopsy of liver metastasis for women with breast cancer: Impact on survival

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

Developing an effective breast cancer vaccine: Challenges to achieving sterile immunity versus resetting equilibrium

Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial

Immunizing against breast cancer: A new swing for an old sword

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab

Results of chest wall resection for recurrent or locally advanced breast malignancies

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

Aktive Filter

Suchergebnisse filtern